Under Armour (UAA) races ahead by double digits on Q1 beat >>> READ MORE

PFE

Recent Articles

Pfizer Inc. (PFE) Stock Could Be a Second-Quarter Star

Pfizer (PFE) looks like it could resume its year-to-date rally soon. If so, it would offer plenty of upside in addition to its 3.8% yield. More 

Biogen Inc (BIIB): Profit From the BIIB Stock Bears

Love it or hate it, the severe chop in Big Pharma presents opportunities to create income. Sell risk against value levels in Biogen (BIIB) stock. More 

Why AbbVie Inc Was a Named Top Dividend Stock (ABBV)

AbbVie Inc has been named to the Dividend Channel's SAFE dividend list based upon these key metrics More 

3 Drug Stocks Hit by Trump’s Call for Lower Prices

While stocks in general are looking weak, pharmaceutical stocks in particular are getting hit. Here are three large-cap drug stocks to avoid. More 

No, Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Isn’t Doomed

Teva Pharmaceutical (TEVA) has more upside than most investors realize. Look past the Copaxone debacle, and TEVA stock is promising. More 

7 Blue-Chip Stocks That Are Flush With Cash

These seven blue-chip stocks each sport recognizable names and enough cash to start their own countries. More 

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Fading Fast

Despite Teva's (TEVA) gains on earnings and rival delays, TEVA stock is still facing impassive sentiment and broad selling pressure. More